Semaglutide programs compared on their own published prices · NexLife prices as of November 6, 2026 · Compare programs →
Home · Guides · BMI Eligibility for Semaglutide
Guide · Updated July 2026

BMI Eligibility for Semaglutide

Released: · Last reviewed:

FDA-approved indications for semaglutide-based weight management (Wegovy) require BMI ≥30 OR BMI ≥27 with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease).

The full picture

Compounded semaglutide eligibility is determined by the licensed prescriber and may follow the same BMI thresholds or use clinical judgment for patients with related metabolic conditions. The legitimate medical use of compounded semaglutide should follow analogous clinical criteria — it should not be prescribed for cosmetic purposes in patients with normal weight. Always discuss eligibility with a licensed clinician.

How NexLife handles this

NexLife is structured around clinical best practices for semaglutide. See full NexLife review.

Disclaimer: This guide is informational and does not constitute medical advice. Decisions about semaglutide should be made in consultation with a licensed healthcare provider who can review your full medical history.
Editor's Pick

NexLife Semaglutide

Compounded semaglutide · clinician oversight

$95/month*

*12-month plan · flat rate · all titration doses

  • From $95/mo (12-mo plan)
  • 503A pharmacies (three named)
  • clinician-reviewed
  • 24/7 support
  • Available U.S. nationwide (varies by state)
Visit NexLife →

Or call (949) 818-8000

Sources & clinical references

Citations supporting clinical and regulatory statements on this page. External links open in a new tab.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.